Considering that the KPC genetically engineered mouse model also highly mimicked the extensive demoplastic status of PDAC, we hypothesized that the AT1 inhibitor irbesartan can sensitize PDAC to chemotherapy by affecting both stromal and tumor cells in KPC genetically engineered mouse model. This evidence concerns the gene AGTR1 and neoplasm.